Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0X4JN
|
||||
| Former ID |
DIB014095
|
||||
| Drug Name |
Pelubiprofen
|
||||
| Synonyms |
Pelubi; Rubione; CS-670; DW-330; RS-2131
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Back pain [ICD9: 724.5,338,780; ICD10:M54, G89, R52] | Approved | [551871] | ||
| Company |
Sankyo Co Ltd
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C16H18O3
|
||||
| Canonical SMILES |
C\1(=C\c2ccc(C(C(=O)O)C)cc2)/C(=O)CCCC1
|
||||
| CAS Number |
CAS 69956-77-0
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cyclooxygenase | Target Info | Modulator | [531590], [551871] | |
| References | |||||
| Ref 531590 | Anti-inflammatory effect of pelubiprofen, 2-[4-(oxocyclohexylidenemethyl)-phenyl]propionic acid, mediated by dual suppression of COX activity and LPS-induced inflammatory gene expression via NF-?B inactivation. J Cell Biochem. 2011 Dec;112(12):3594-603. | ||||
| Ref 551871 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.